Antares pharma, inc. (ATRS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue:
Total revenue

33,079

37,839

34,306

28,433

23,286

18,821

17,868

14,162

12,703

-

15,052

13,416

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

10,037

-

11,049

8,690

10,841

9,042

8,027

5,840

4,623

4,470

3,559

3,360

1,805

905

3,047

4,512

2,492

1,379

2,052

3,211

2,494

1,809

2,197

2,218

1,405

1,654

1,151

Licensing and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

1,640

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,101

3,267

1,098

867

2,608

3,027

2,388

2,291

1,744

1,788

1,421

1,458

1,299

588

793

1,092

2,606

737

2,986

1,737

952

716

1,056

-

-

Development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

401

497

Licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

38

50

1,129

42

5,186

883

925

926

928

928

641

69

68

69

1,329

77

109

625

612

123

118

366

582

1,043

Royalties

-

-

-

-

-

-

-

-

-

-

-

-

330

-

289

232

328

763

407

366

453

714

339

250

1,047

1,739

1,092

667

1,172

1,700

949

465

758

1,267

646

489

741

483

357

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

12,007

-

13,478

12,228

12,318

11,803

11,085

14,420

8,348

8,402

6,570

6,326

5,202

4,744

5,507

5,837

4,528

5,501

5,685

4,523

6,864

5,427

3,919

3,542

3,569

3,122

3,050

Cost of revenue:
Total cost of revenue

15,047

14,026

13,062

12,441

10,946

9,630

7,289

6,960

7,186

-

8,523

5,617

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

5,448

-

7,206

5,216

6,247

5,161

3,265

2,540

1,957

4,337

2,158

1,846

1,017

470

1,909

3,182

1,427

1,045

1,673

2,028

1,368

881

1,028

1,001

711

798

592

Cost of development revenue

-

-

-

-

-

-

-

-

-

-

-

-

771

-

827

2,101

528

814

1,833

2,167

1,717

1,084

349

283

159

214

1,095

297

599

656

1,622

502

622

1,262

778

391

741

-

-

Cost of development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

280

403

Total cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

6,219

-

8,033

7,318

6,775

5,975

5,099

4,708

3,674

5,422

2,507

2,130

1,176

684

3,004

3,480

2,027

1,702

3,296

2,531

1,990

2,144

1,807

1,393

1,452

1,079

995

Gross profit

18,032

23,813

21,244

15,992

12,340

9,191

10,579

7,202

5,517

6,933

6,529

7,799

5,788

7,506

5,445

4,910

5,543

5,828

5,985

9,712

4,673

2,979

4,063

4,196

4,025

4,060

2,503

2,356

2,501

3,799

2,389

1,992

4,873

3,283

2,111

2,149

2,116

2,042

2,055

Operating expenses:
Research and development

2,981

2,880

2,863

2,494

2,387

3,007

3,191

3,230

2,900

2,319

3,289

3,159

3,087

4,037

5,958

3,948

5,648

5,641

5,142

4,568

4,377

5,734

4,426

3,942

4,533

3,477

4,318

4,395

3,072

5,661

3,900

2,482

2,877

1,574

1,429

1,946

1,749

2,332

2,242

Selling, general and administrative

16,422

15,366

16,385

15,087

14,935

11,896

8,747

7,883

8,236

8,633

8,186

7,360

7,467

7,689

5,622

7,014

7,603

6,677

6,611

6,605

7,037

7,285

6,810

9,344

8,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

19,403

18,246

19,248

17,581

17,322

14,903

11,938

11,113

11,136

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and marketing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,576

1,158

881

-

237

187

103

-

390

523

288

204

241

Business development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

219

231

332

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,978

1,933

1,950

-

1,551

1,881

1,657

3,073

1,559

1,276

1,490

1,170

1,121

Total operating expenses

-

-

-

-

-

-

-

-

-

-

11,475

10,519

10,554

-

11,581

10,962

13,251

12,319

11,753

11,173

11,415

13,019

11,236

13,287

12,833

10,007

8,872

7,487

5,904

8,843

5,908

4,783

4,970

3,445

3,378

3,745

3,528

3,707

3,606

Operating loss

-1,371

5,567

1,996

-1,589

-4,982

6,788

-1,359

-3,911

-5,619

-3,159

-4,946

-2,720

-4,766

-4,220

-6,136

-6,052

-7,708

-6,491

-5,767

-1,461

-6,741

-10,040

-7,173

-9,091

-8,808

-5,947

-6,369

-5,130

-3,403

-5,044

-3,519

-2,790

-97

-162

-1,266

-1,596

-1,411

-1,664

-1,550

Other income (expense):
Interest expense

1,061

1,079

1,097

712

661

716

674

654

631

-

626

168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

76

207

144

75

104

62

97

45

57

74

119

48

30

-180

15

-9

52

39

29

-45

-45

-84

-12

-6

13

-90

9

27

-5

-44

-15

-16

22

-27

-32

42

30

-

-

Total other expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

-1

Net loss

-2,356

4,695

1,043

-2,226

-5,539

6,134

-1,936

-4,520

-6,193

-3,714

-5,453

-2,840

-4,736

-4,500

-6,120

-6,061

-7,656

-6,626

-5,738

-1,506

-6,787

-10,072

-7,186

-9,097

-8,794

-5,635

-6,359

-5,103

-3,408

-5,011

-3,534

-2,807

-74

-153

-1,299

-1,554

-1,380

-1,631

-1,552

Net loss per common share, basic and diluted

-0.01

0.02

0.01

-0.01

-0.03

0.04

-0.01

-0.03

-0.04

-0.03

-0.03

-0.02

-0.03

-0.03

-0.04

-0.04

-0.05

-0.04

-0.04

-0.01

-0.05

-0.08

-0.05

-0.07

-0.07

-0.04

-0.05

-0.04

-0.03

-

-0.03

-0.03

-

-

-

-

-

-0.02

-0.02

Basic

-

-

163,119

-

-

-

157,471

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

168,503

-

-

-

157,471

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, basic and diluted

165,429

-

-

162,734

160,446

-

-

157,024

156,724

156,674

156,401

155,926

155,215

155,113

155,060

154,936

154,858

155,172

154,808

144,650

131,744

131,719

130,771

130,051

129,656

127,857

127,162

126,462

126,106

-

108,961

104,551

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-0.01

-0.02

-0.02

-

-

Basic and diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

103,658

-

103,311

95,157

85,719

83,615

82,912

Product sales [Member]
Total revenue

27,097

28,496

24,687

20,620

18,300

14,229

11,597

11,095

10,949

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

14,014

12,476

12,510

10,713

10,568

8,899

6,982

6,677

6,536

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensing and Development Revenue [Member]
Total revenue

1,755

3,164

1,211

2,239

915

1,129

2,554

1,785

1,285

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties [Member]
Total revenue

4,227

6,179

8,408

5,574

4,071

3,463

3,717

1,282

469

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of development revenue [Member]
Total cost of revenue

1,033

1,550

552

1,728

378

731

307

283

650

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-